fda safety communication semaglutide naion 2025 linked to increased risk of vision loss in diabetes patients fda drug safety communication naion

Natural Weight Loss : Natural weight loss is slower since it relies on lifestyle changes and gradual fat reduction

Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands

[8] [9] As a precautionary measure, consistent with SmPC guidance for the drug class, retatrutide would be expected to be contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Patients who are pregnant, breastfeeding, or planning pregnancy should not use retatrutide, consistent with guidance applicable to other agents in this class

Synaptic adaptations by alcohol and drugs of abuse: changes in microRNA expression and mRNA regulation